Context Therapeutics Inc. buy BiotechBee
Start price
24.06.23
/
60%
€1.14
Target price
31.12.25
€3.00
Performance (%)
12.28%
End price
14.12.24
€1.28
Summary
This prediction ended on 14.12.24 with a price of €1.28. The prediction had a final performance of 12.28%. BiotechBee has 60% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Context Therapeutics Inc. | -11.404% | -11.404% | 210.769% |
| iShares Core DAX® | 4,24 % | 2,86 % | 14,03 % |
| iShares Nasdaq 100 | 4,89 % | 2,81 % | 32,71 % |
| iShares Nikkei 225® | 9,40 % | 7,83 % | 48,30 % |
| iShares S&P 500 | 3,53 % | 1,95 % | 25,25 % |
According to BiotechBee what are the pros and cons of Context Therapeutics Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year